Adalimumab
Adalimumab (Humira) appears in one listed auto-injector, the named brand. This monoclonal antibody is used for inflammatory autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. The device, strength and product directions define the formulation. Listed products differ in ingredient profile, form, strength, and pack size.
How does adalimumab work?
Adalimumab binds to tumour necrosis factor, or TNF, an immune signalling protein involved in inflammation. Humira addresses Rheumatoid Arthritis and Psoriatic Arthritis, within Autoimmune Support.
Important safety information for Adalimumab
Information about Adalimumab on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.